Dow Up 0.51% Nasdaq Up 0.24%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
53.05 Down 0.46(0.86%) Nov 21, 4:00PM EST
|After Hours : 53.05 0.00 (0.00%) Nov 21, 5:00PM EST
Prev Close:53.51
Open:54.43
Bid:52.85 x 100
Ask:55.00 x 100
1y Target Est:87.50
Beta:2.04
Earnings Date:Feb 9 - Feb 13 (Est.)
Day's Range:52.61 - 54.50
52wk Range:41.99 - 80.42
Volume:203,429
Avg Vol (3m):392,257
Market Cap:1.06B
P/E (ttm):160.76
EPS (ttm):0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LGNDDown 0.86%1.06B
LLYUp 0.84%72.05B
MRKUp 0.47%170.08B
RHHBYDown 1.04%253.38B

Key Statistics

Forward P/E (1 yr):22.67
P/S (ttm):19.04
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.53
Quarterly EPS Est (Dec-14) :0.61
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.17

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback